Veloxis Pharmaceuticals Company Profile

Aggregated data from the web about Veloxis Pharmaceuticals

Company Name	Veloxis Pharmaceuticals
Website	www.veloxis.com
Snippet	Veloxis is a specialty pharmaceutical company committed to improving the lives of transplant patients. Our unique, patented delivery technology, MeltDose®, is designed to enhance the absorption and bioavailability of select orally administered drugs.
Type	Aktieselskab
Founded	2002
Revenue	14,150,000 Danish krone
Website	www.veloxis.com
Industry	Pharmaceuticals
Products	Orally-delivered pharmaceuticals
Traded as	Nasdaq Copenhagen: VELO
Key people	Craig Collard (CEO), Michael Heffernan (Chairman)
Net income	−176,106,000 Danish krone
Headquarters	Hørsholm, Denmark
Number of employees	51

Veloxis Pharmaceuticals is part of the Denmark company list

Veloxis Pharmaceuticals is part of the Pharmaceuticals company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.